Samsung Bioepis Co., Ltd. vs. Janssen Biotech, Inc.
Explore the PTAB proceeding IPR2023-01103 filed by Samsung Bioepis Co., Ltd. on 2023-06-21. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2023-01103
Filing Date
2023-06-21
Accorded Filing Date
2023-07-21
Institution Decision Date
โ
Last Modified Date
โ
Proceeding Type
IPR
Termination Date
2023-08-09
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Samsung Bioepis Co., Ltd.
Represented By
Frank, Noahet alPatent Owner / Respondent
Janssen Biotech, Inc.
Represented By
Morin, Michaelet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 32019 | Paul Coletti | +1 908-230-8324 |
| 32501 | Hal Woodrow | +1 732-718-1308 |
| 33797 | Yuriy Stercho | +1 610-420-6303 |
| 33833 | Kirk Baumeister | +1 484-418-8440 |
| 33967 | Karen Harding | +1 904-443-3074 |
| 35152 | Rebecca Barrett | +1 215-628-5142 |
| 35490 | Thomas Dimauro | +1 508-624-9627 |
| 37107 | Louis Capezzuto | +1 732-524-2218 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 6 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 10,961,307 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2021017162 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2024018255 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2018627355 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2018627698 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2019628957 | US Continuation / Sibling | View Official Patent → |
Biocon Biologics Inc. et al. v. Janssen Biotech, Inc.
Standard Essential Patent (SEP) & FRAND Intelligence
5G SEP โข ETSI Declared High-Probability SEP ActionEssential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation
Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)
Permanent Injunction RestrictedAsserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.